The share of the largest Russian pharmaceutical distributor continues to decline

In the first quarter of 2020 continued reduction in the share of the largest Russian pharmaceutical distributors. The crisis in the market contributed to the increase in the share of only one company – distributor of pharmaceutical products “Irvin 2” significantly increased volume of sales (its share of shipments increased from 1% to 1.8%).

“High demand, as one would expect, had a rather short-term effect, the panic began in late February and March, the peak of the increased demand, and in mid-April, the market has returned to full standard trends of stagnation. The dynamics of the uneven development of different market sectors was maintained, the public sector as a whole grew more rapidly than retail, even though COVID-19” – analysts RNC Pharma. According to the research firm, the share of the largest Russian pharmaceutical distributor continues to decline for the third year in a row.

Thus, the share of the largest a pharmaceutical distributor “Pulse” declined to 15.4% (in the first quarter of 2019, it was 16.2%). The second place ranking RNC Pharma is a PROTEK and its share dropped by nearly 3% – up from 16.1% to 13.4%. In third place is Novosibirsk “quatrain” with a share of 11.8% (instead of 14.5% a year earlier).

Against the background of General decline is the “Irvine 2”. Although the company now occupies a modest 1.8% share in the previous year it was still below 1%. Importantly, this distributor of pharmaceutical products was only one of the TOP 15 who was able to increase its market share despite the challenging environment.

Photo: Halawi / Shutterstock.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

“Nanolek” released the first batch of hydroxychloroquine

The company “Nanolek” factory in the Kirov region has established the production of one of the drugs for the treatment of coronavirus infection of hydroxychloroquine. Currently, hydroxychloroquine is included in the treatment protocols in the interim Ministry of health recommendations for the prevention, diagnosis and treatment of new coronavirus infection. The first batch of this […]

Igor Ghahramanyan was returned to the Ministry of health

Senator Igor Ghahramanyan was appointed first Deputy Minister of health of the Russian Federation. In the Federation Council Ghahramanyan presented the Executive authority of the Yaroslavl region and held the position of first Deputy Chairman of Committee on social policy, writes “Kommersant”. From 2012 to 2017 Igor Ghahramanyan was already a Deputy and first Deputy […]

AstraZeneca localized in Russia production of ticagrelor

Company AstraZeneca localized at its own plant in Kaluga region manufacture of the finished dosage form of ticagrelor 90 mg for the treatment of patients with acute coronary syndrome (ACS). Ticagrelor (trade name of Brilinta) is included in the list of essential drugs and included in the standards of specialized medical care for patients with […]